Your losing sight of the real value of the drug. Put aside the fact J.Z., FDA, ADCOM flubbed up!
And some folks are losing sight of reality - is anyone here actually in the green on their investment in AMRN? I don't care how darn good the drug works (and it does so wonderfully, as I take it myself) - if it's not selling enough (and it isn't, be honest here), the stock has been crushed, the FDA and BP are in a conspiracy to crush AMRN, "flubs" intentional or not, this stock has been a disaster for nearly all of us. With ARNA, at least the science backed the drug's safety and efficacy in the end - Vascepa is equally protected by the science - the problem is the FDA has decided to dictate the practice of medicine, saying TGs 200-500 need not be treated (at least not by EPA) - that's a huge difference. In our case, not only were the goalposts moved mid-game, the entire playing field was changed!